We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 6,568

Patentability of Genetic Material - Australian Rules
  • GQ Life Sciences
  • Australia, USA
  • May 25 2016

After the United States Supreme Court ruling in the Association for Molecular Pathology v. Myriad Genetics in June of 2013, the industry scurried


US: Federal Circuit denies venue transfer in TC Heartland
  • Hogan Lovells
  • USA
  • May 25 2016

In follow up to our earlier post the Court of Appeals for the Federal Circuit has denied TC Heartland LLC’s (“TC”) petition for a writ of mandamus to


Updated USPTO guidance for biotech claims
  • Baker Donelson Bearman Caldwell & Berkowitz PC
  • USA
  • May 25 2016

On May 5 2016 the US Patent and Trademark Office (USPTO) published an update to its existing guidelines on patent-eligible subject matter under 35


Calculating SPC application period based on variation of existing marketing authorisation
  • Preslmayr Attorneys at Law
  • Austria, European Union
  • May 25 2016

The period available to apply for a supplementary protection certificate (SPC) commences only once a marketing authorisation has been obtained for a


A finding of a settlement agreement is overturned because counsel did not have the authority to bind his client
  • Borden Ladner Gervais LLP
  • Canada
  • May 25 2016

The Federal Court of Appeal has overturned the earlier finding that Allergan and Apotex had settled their patent infringement litigation (2015 FC


CAFC Affirms Finacea Gel Infringement Under Doctrine Of Equivalents
  • Foley & Lardner LLP
  • USA
  • May 24 2016

In Intendis GmbH v. Glenmark Pharmaceuticals Inc., USA, the Federal Circuit affirmed the district court decision that found infringement under the


Wyeth taken by Carr to winning position in vaccine battle
  • Bristows LLP
  • United Kingdom
  • May 24 2016

Bexsero, the Meningitis B vaccine marketed by GSK, has been the subject of many newspaper headlines in the UK over the last year, with parents


Brexit First Aid for Pharma
  • Hogan Lovells
  • European Union, United Kingdom
  • May 24 2016

Should the UK choose to leave the EU, there will be a substantial impact for the UK pharmaceutical industry. Crucially, these implications will not


FTC Maintains Aggressive Stance Against Pay-for-Delay Dealsh1
  • Manatt Phelps & Phillips LLP
  • USA
  • May 24 2016

A recent complaint filed by the Federal Trade Commission (FTC) indicates that the agency is continuing its aggressive pursuit of agreements between


Combination claim credible on Carr’s construction
  • Bristows LLP
  • United Kingdom
  • May 23 2016

Carr J has upheld the validity of Wyeth’s patent EP(UK) 2,343,308 relating to a combination product comprising a 2086 protein and a PorA protein used